SYNAGEVA BIOPHARMA CORP: key financial figures for fiscal year 2014 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2014)
- $6.5M
- Net Income/Loss (FY2014)
- -$192.6M
- Total Assets (FY2014)
- $504.2M
- Total Equity (FY2014)
- $473.2M
- Cash Flows from Operating Activities (FY2014)
- -$150.1M
Source: SYNAGEVA BIOPHARMA CORP 10-K filing (FY2014). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
